ArticleInternational journal of clinical oncology2026

Phase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

Yuko Shirouchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.